Diversified Trust Co decreased its position in athenahealth Inc. (NASDAQ:ATHN) by 12.2% during the second quarter, Holdings Channel reports. The institutional investor owned 4,465 shares of the company’s stock after selling 620 shares during the period. Diversified Trust Co’s holdings in athenahealth were worth $616,000 at the end of the most recent quarter.
Several other large investors also recently made changes to their positions in ATHN. Geode Capital Management LLC raised its position in athenahealth by 4.6% in the first quarter. Geode Capital Management LLC now owns 245,893 shares of the company’s stock worth $34,125,000 after buying an additional 10,803 shares during the last quarter. State Street Corp raised its position in athenahealth by 3.2% in the first quarter. State Street Corp now owns 457,047 shares of the company’s stock worth $63,430,000 after buying an additional 14,099 shares during the last quarter. Riverhead Capital Management LLC acquired a new position in athenahealth during the first quarter worth $984,000. Loomis Sayles & Co. L P acquired a new position in athenahealth during the first quarter worth $1,871,000. Finally, Pitcairn Co. raised its position in athenahealth by 7.7% in the second quarter. Pitcairn Co. now owns 3,094 shares of the company’s stock worth $427,000 after buying an additional 221 shares during the last quarter.
athenahealth Inc. (NASDAQ:ATHN) traded down 0.11% during trading on Monday, reaching $123.69. The company’s stock had a trading volume of 167,978 shares. The company has a market cap of $4.87 billion, a PE ratio of 454.74 and a beta of 1.15. athenahealth Inc. has a 52-week low of $114.59 and a 52-week high of $170.42. The stock has a 50-day moving average price of $122.99 and a 200 day moving average price of $130.37.
athenahealth (NASDAQ:ATHN) last announced its quarterly earnings results on Thursday, July 21st. The company reported $0.34 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.42 by $0.08. The company earned $261.90 million during the quarter, compared to analysts’ expectations of $274.07 million. athenahealth had a net margin of 1.06% and a return on equity of 5.16%. On average, analysts expect that athenahealth Inc. will post $1.77 EPS for the current year.
A number of research analysts recently weighed in on the company. Deutsche Bank AG lowered athenahealth from a “buy” rating to a “hold” rating and decreased their target price for the stock from $165.00 to $147.00 in a report on Friday, July 22nd. Jefferies Group reissued an “underperform” rating and set a $105.00 target price on shares of athenahealth in a report on Monday, July 25th. Zacks Investment Research raised athenahealth from a “sell” rating to a “hold” rating in a report on Thursday, August 4th. Morgan Stanley decreased their target price on athenahealth from $186.00 to $153.00 and set an “overweight” rating on the stock in a report on Monday, July 25th. Finally, Canaccord Genuity reaffirmed a “hold” rating and issued a $142.00 price objective on shares of athenahealth in a report on Wednesday, June 29th. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and eight have issued a buy rating to the company. athenahealth presently has an average rating of “Hold” and a consensus price target of $149.58.
In other news, Director Brandon H. Hull sold 800 shares of athenahealth stock in a transaction on Friday, July 1st. The stock was sold at an average price of $137.48, for a total value of $109,984.00. Following the completion of the transaction, the director now directly owns 6,387 shares in the company, valued at $878,084.76. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Jonathan Bush sold 4,000 shares of the business’s stock in a transaction dated Friday, July 1st. The stock was sold at an average price of $138.21, for a total value of $552,840.00. Following the transaction, the chief executive officer now owns 312,109 shares of the company’s stock, valued at $43,136,584.89. The disclosure for this sale can be found here. 3.04% of the stock is owned by insiders.
athenahealth Company Profile
athenahealth, Inc is a provider of cloud-based services and mobile applications for medical groups and health systems. The Company delivers cloud-based services for revenue cycle management and medical billing, electronic health records (EHR), patient engagement, care coordination, order transmission, population health management, and clinical decision support.
Want to see what other hedge funds are holding ATHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for athenahealth Inc. (NASDAQ:ATHN).
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.